CELG. Celgene Corporation Announces Pomalidomide Will Be Reviewed at FDA Advisory Committee ODAC will discuss pomalidomide NDA for the treatment of patients with relapsed and refractory multiple myeloma
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.